JP Patent

JP2007536350A — 肺気腫の予防又は治療のためのロフルミラストの使用

Assigned to Takeda GmbH · Expires 2007-12-13 · 18y expired

What this patent protects

本発明は、肺気腫の予防のためのロフルミラストの使用に関する。

USPTO Abstract

本発明は、肺気腫の予防のためのロフルミラストの使用に関する。

Drugs covered by this patent

Yupelri (REVEFENACIN) · Mylan Ireland Ltd

Patent Metadata

Patent number: JP2007536350A
Jurisdiction: JP
Classification: —
Expires: 2007-12-13
Drug substance claim: No
Drug product claim: No
Assignee: Takeda GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.